Web11 mei 2024 · The agenda for the meeting is as follows: 2:00 p.m. 2:10 p.m. PT Annual Meeting of Stockholders (for stockholders of record as of March 31, 2024) 2:10 p.m. 3:00 … Web31 jan. 2024 · For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing the standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry leading neurological and cardiometabolic franchises.
Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals …
Web9 jan. 2024 · Presentations March 30, 2024 Corporate Overview10.4 MB March 1, 2024 4Q22 Earnings Presentation6.8 MB January 9, 2024 Jazz Pharmaceuticals JPM 2024 Presentation9.1 MB About Nav About Leadership Board of Directors Global Footprint History Corporate Values Corporate Development Manufacturing News Careers Medicines Nav … Web4 apr. 2024 · Overview. Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. rcmp sherwood park ab
Ionis to host 2024 virtual Annual Meeting of Stockholders - PR …
Web6 apr. 2024 · Ionis Pharmaceuticals (IONS) Presents On Neurology Franchise - Slideshow SA Transcripts Tue, Jul. 14, 2024 15 Comments Ionis Pharmaceuticals, Inc. (IONS) Management Presents at BMO 2024... Web1 uur geleden · Flamingo has an alliance with Ionis Pharmaceuticals and is supported by well-known biotechnology investors including Andera Partners, Bpifrance Large Venture, Bpifrance through its FABS and... http://investor.jazzpharma.com/investors/events-presentations rcmp shediac office